Expert Opinion on Pharmacotherapy
Volume 24, 2023 - Issue 7
Open access
2,136
Views
0
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Evaluation
Pharmacoeconomics of novel pharmacotherapies in triple-negative breast cancer
Luca Boscolo Bieloa Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy;b Department of Oncology and Haematology, University of Milan, Milan, ItalyView further author information
, Dario Trapania Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy;b Department of Oncology and Haematology, University of Milan, Milan, Italyhttps://orcid.org/0000-0003-1672-9560View further author information
& Giuseppe Curiglianoa Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy;b Department of Oncology and Haematology, University of Milan, Milan, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-1781-2518View further author information
https://orcid.org/0000-0003-1781-2518View further author information
Pages 789-801
|
Received 22 Jan 2023, Accepted 06 Apr 2023, Published online: 11 Apr 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.